The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D05 | Antipsoriatics | |
| 3 | D05A | Antipsoriatics for topical use | |
| 4 | D05AX | Other antipsoriatics for topical use | |
| 5 | D05AX05 | Tazarotene |
| Active Ingredient | Description | |
|---|---|---|
| Tazarotene |
Tazarotene, a member of the acetylenic class of retinoids, is a prodrug which is converted to its active free form, tazarotenic acid, by de-esterification in the skin area. Tazarotenic acid is the only known metabolite of tazarotene to have retinoid activity. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| TAZORAC Cream | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| TAZORAC Gel | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| ZORAC Gel | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
